| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Kristin Galetta, Sophia Ryan, Giovanna Manzano, Lori B Chibnik, Denis Balaban, Sashank Prasad, Bart K Chwalisz, Andrea Salazar-Camelo, Sarah Conway, Michael Levy, Marcelo Matiell. Treatment outcomes of first-ever episode of severe optic neuritis. Multiple sclerosis and related disorders. vol 66. 2022-07-15. PMID:35839615. |
severe optic neuritis (on) is an acute inflammatory attack of the optic nerve(s) leading to severe visual loss that may occur in isolation or as part of a relapsing neuroinflammatory disease, such neuromyelitis optica spectrum disorder (nmosd), myelin oligodendrocyte glycoprotein antibody associated disease (mogad), or more rarely multiple sclerosis (ms). |
2022-07-15 |
2023-08-14 |
Not clear |
| Tianrong Yeo, Amy May Lin Quek, Kok Pin Yong, Janis Siew Noi Tye, Pavanni Ratnagopal, Derek Tuck Loong Soon, Kevin Ta. COVID-19 infection after two doses of SARS-CoV-2 mRNA vaccine in multiple sclerosis, AQP4-antibody NMOSD and MOGAD. Multiple sclerosis and related disorders. vol 65. 2022-07-08. PMID:35803084. |
it is still not known if such observations extend to vaccinated individuals and there have been considerably fewer studies in aquaporin-4-antibody neuromyelitis optica spectrum disorder (aqp4-nmosd) and myelin oligodendrocyte glycoprotein-antibody associated disease (mogad) patients. |
2022-07-08 |
2023-08-14 |
Not clear |
| Alicja Kalinowska-Łyszczarz, Yong Guo, Claudia F Lucchinett. Update on pathology of central nervous system inflammatory demyelinating diseases. Neurologia i neurochirurgia polska. 2022-06-27. PMID:35758517. |
also, we define differences in the pathology of ms, acute disseminated encephalomyelitis (adem), aquaporin 4-igg positive (aqp4-igg+) neuromyelitis optica spectrum disorder (nmosd), and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). |
2022-06-27 |
2023-08-14 |
Not clear |
| Mario Gonzalez-Gronow, Salvatore Vincent Pizz. Physiological Roles of the Autoantibodies to the 78-Kilodalton Glucose-Regulated Protein (GRP78) in Cancer and Autoimmune Diseases. Biomedicines. vol 10. issue 6. 2022-06-24. PMID:35740249. |
they are also found in autoimmune pathologies such as rheumatoid arthritis (ra), neuromyelitis optica (nmo), anti-myelin oligodendrocyte glycoprotein antibody-associated disorder (amogad), lambert-eaton myasthenic syndrome (lems), multiple sclerosis (ms), neuropsychiatric systemic lupus erythematosus (npsle) and type 1 diabetes (t1d). |
2022-06-24 |
2023-08-14 |
Not clear |
| Wei Jiang, Xuan Sun, Huasheng Huang, Hui Sun, Shimin Zhang, Mianwang He, Xiaojun Yu, Dehui Huang, Lei W. Bilateral parafalcine cortical and leptomeningeal impairment in MOG antibody disease and AQP4 neuromyelitis optica. Journal of neuroimmunology. vol 369. 2022-06-19. PMID:35717737. |
bilateral parafalcine cortical and leptomeningeal impairment (bpcli) is a rare finding observed in cases of myelin oligodendrocyte glycoprotein (mog) antibody disease (mogad) and neuromyelitis optica spectrum disorders (nmosd). |
2022-06-19 |
2023-08-14 |
Not clear |
| Rajendra Singh Jain, Deepak Jain, Sourabh Murarka, Arvind Vyas, Bhawna Sharma, Trilochan Srivastava, Kamlesh Kumar, Yavnika Jain, Kavya Rao, Jitesh Agrawal, Shankar Tejwan. Comparison of Clinical and Radiological Features of Aquaporin4 (AQP-4) Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD) and Anti Myelin Oligodendrocyte Glycoprotein (Anti-MOG) Syndrome-Our Experience from Northwest India. Annals of Indian Academy of Neurology. vol 25. issue 2. 2022-06-13. PMID:35693673. |
comparison of clinical and radiological features of aquaporin4 (aqp-4) antibody positive neuromyelitis optica spectrum disorder (nmosd) and anti myelin oligodendrocyte glycoprotein (anti-mog) syndrome-our experience from northwest india. |
2022-06-13 |
2023-08-14 |
Not clear |
| Er-Chuang Li, Yang Zheng, Meng-Ting Cai, Qi-Lun Lai, Gao-Li Fang, Bing-Qing Du, Chun-Hong Shen, Yin-Xi Zhang, Long-Jun Wu, Mei-Ping Din. Seizures and epilepsy in multiple sclerosis, aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease. Epilepsia. 2022-06-02. PMID:35652436. |
seizures and epilepsy in multiple sclerosis, aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease. |
2022-06-02 |
2023-08-14 |
Not clear |
| Er-Chuang Li, Yang Zheng, Meng-Ting Cai, Qi-Lun Lai, Gao-Li Fang, Bing-Qing Du, Chun-Hong Shen, Yin-Xi Zhang, Long-Jun Wu, Mei-Ping Din. Seizures and epilepsy in multiple sclerosis, aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease. Epilepsia. 2022-06-02. PMID:35652436. |
seizure is one of the manifestations of central nervous system (cns) inflammatory demyelinating diseases, which mainly include multiple sclerosis (ms), aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder (aqp4-nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad). |
2022-06-02 |
2023-08-14 |
Not clear |
| Zhenghao Duan, Juan Fen. Comparison of neutrophil-to-lymphocyte ratio between myelin oligodendrocyte glycoprotein antibody-associated disease and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders in adults. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. vol 101. 2022-05-15. PMID:35569419. |
comparison of neutrophil-to-lymphocyte ratio between myelin oligodendrocyte glycoprotein antibody-associated disease and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders in adults. |
2022-05-15 |
2023-08-13 |
Not clear |
| Itay Lotan, Gabriela Romanow, Michael Levy, Ilya Kiste. Is there a link between neuropathic pain and constipation in NMOSD and MOGAD? Results from an online patient survey and possible clinical implications. Multiple sclerosis and related disorders. vol 63. 2022-05-10. PMID:35537276. |
neuropathic pain (np) and constipation are common among people with neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein antibody disease (mogad) and have a negative impact on quality-of-life measures. |
2022-05-10 |
2023-08-13 |
Not clear |
| Reuben Foo, Christine Yau, Shweta Singhal, Sharon Tow, Jing-Liang Loo, Kevin Tan, Dan Mile. Optic Neuritis in the Era of NMOSD and MOGAD: A Survey of Practice Patterns in Singapore. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.). vol 11. issue 2. 2022-05-09. PMID:35533337. |
in the advent of antibody testing for neuromyelitis optica spectrum disease (nmosd) and myelin oligodendrocyte glycoprotein antibody-associated disease (mogad), emerging concepts, such as routine antibody testing and management, remain controversial, resulting mostly from studies in white populations. |
2022-05-09 |
2023-08-13 |
Not clear |
| Xiayin Yang, Xuefen Li, Mengying Lai, Jincui Wang, Shaoying Tan, Henry Ho-Lung Cha. Pain Symptoms in Optic Neuritis. Frontiers in pain research (Lausanne, Switzerland). vol 3. 2022-05-02. PMID:35498555. |
this article reviews the presence of pain related to on with respect to underlying disorders, including multiple sclerosis (ms), neuromyelitis optica spectrum disorder (nmosd), and myelin oligodendrocyte glycoprotein associated disease (mogad). |
2022-05-02 |
2023-08-13 |
Not clear |
| Tetsuya Akaishi, Noriko Himori, Takayuki Takeshita, Tatsuro Misu, Toshiyuki Takahashi, Yoshiki Takai, Shuhei Nishiyama, Kimihiko Kaneko, Juichi Fujimori, Tadashi Ishii, Masashi Aoki, Kazuo Fujihara, Toru Nakazawa, Ichiro Nakashim. Follow-up of retinal thickness and optic MRI after optic neuritis in anti-MOG antibody-associated disease and anti-AQP4 antibody-positive NMOSD. Journal of the neurological sciences. vol 437. 2022-04-28. PMID:35483239. |
retinal atrophy in the chronic phase of optic neuritis (on) in anti-aquaporin-4 antibody (aqp4-ab)-positive neuromyelitis optica spectrum disorder (nmosd) and anti-myelin oligodendrocyte glycoprotein antibody-associated disease (mogad) remains unclear. |
2022-04-28 |
2023-08-13 |
Not clear |
| Ashraf Valappil, Ragesh Radhakrishnan Nair, Sudha Madhusoodhanan, Anoop Narendra. Rhombencephalomyelitis due to possible paraneoplastic syndrome associated with Hodgkin's lymphoma. BMJ case reports. vol 15. issue 4. 2022-04-22. PMID:35450877. |
cerebrospinal fluid analysis, serum myelin oligodendrocyte glycoprotein, neuromyelitis optica antibodies, vasculitis work-up, onconeural antibody panel and whole-body fluorodeoxyglucose-positron emission tomography scan were all unrevealing, and she was kept under close follow-up. |
2022-04-22 |
2023-08-13 |
Not clear |
| Jae-Won Hyun, Yeseul Kim, Ki Hoon Kim, Su-Hyun Kim, Mads Nikolaj Olesen, Nasrin Asgari, Sasitorn Siritho, Friedemann Paul, Ho Jin Ki. CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage. Journal of neuroinflammation. vol 19. issue 1. 2022-04-13. PMID:35413922. |
despite rigorous confirmation with reliable assays, some individuals showing the neuromyelitis optica spectrum disorder (nmosd) phenotype remain negative for both aquaporin-4 (aqp4) and myelin oligodendrocyte glycoprotein (mog) antibodies. |
2022-04-13 |
2023-08-13 |
Not clear |
| Caterina Allegretta, Emanuele D'Amico, Virginia Manuti, Carlo Avolio, Massimo Cones. Mesenchymal Stem Cell-Derived Extracellular Vesicles and Their Therapeutic Use in Central Nervous System Demyelinating Disorders. International journal of molecular sciences. vol 23. issue 7. 2022-04-12. PMID:35409188. |
autoimmune demyelinating diseases-including multiple sclerosis, neuromyelitis optica spectrum disorder, anti-myelin oligodendrocyte glycoprotein-associated disease, acute disseminated encephalomyelitis, and glial fibrillary acidic protein (gfap)-associated meningoencephalomyelitis-are a heterogeneous group of diseases even though their common pathology is characterized by neuroinflammation, loss of myelin, and reactive astrogliosis. |
2022-04-12 |
2023-08-13 |
Not clear |
| Alessandro Dinoto, Elia Sechi, Eoin P Flanagan, Sergio Ferrari, Paolo Solla, Sara Mariotto, John J Che. Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease. Frontiers in neurology. vol 13. 2022-04-11. PMID:35401423. |
serum and cerebrospinal fluid biomarkers in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disease. |
2022-04-11 |
2023-08-13 |
Not clear |
| Liang Wang, Hongmei Tan, Wenjuan Huang, Xuechun Chang, Jingzi ZhangBao, Lei Zhou, Chuanzhen Lu, Min Wang, Jiahong Lu, Chongbo Zhao, Chao Qua. Late onset neuromyelitis optica spectrum disorder with anti-aquaporin 4 and anti-myelin oligodendrocyte glycoprotein antibodies. European journal of neurology. vol 29. issue 4. 2022-04-04. PMID:34967093. |
late onset neuromyelitis optica spectrum disorder with anti-aquaporin 4 and anti-myelin oligodendrocyte glycoprotein antibodies. |
2022-04-04 |
2023-08-16 |
Not clear |
| Yunjie Li, Xia Liu, Jingxuan Wang, Chao Pan, Zhouping Tan. Clinical Features and Imaging Findings of Myelin Oligodendrocyte Glycoprotein-IgG-Associated Disorder (MOGAD). Frontiers in aging neuroscience. vol 14. 2022-04-04. PMID:35370624. |
myelin oligodendrocyte glycoprotein-igg-associated disorder (mogad) is a nervous system (ns) demyelination disease and a newly recognized distinct disease complicated with various diseases or symptoms; however, mogad was once considered a subset of neuromyelitis optica spectrum disorder (nmosd). |
2022-04-04 |
2023-08-13 |
Not clear |
| Vyanka Redenbaugh, Eoin P Flanaga. Monoclonal Antibody Therapies Beyond Complement for NMOSD and MOGAD. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2022-03-10. PMID:35267170. |
aquaporin-4 (aqp4)-igg seropositive neuromyelitis optica spectrum disorders (aqp4-igg seropositive nmosd) and myelin oligodendrocyte glycoprotein (mog)-igg-associated disease (mogad) are inflammatory demyelinating disorders distinct from each other and from multiple sclerosis (ms).while anti-cd20 treatments can be used to treat ms and aqp4-igg seropositive nmosd, some ms medications are ineffective or could exacerbate aqp4-igg seropositive nmosd including beta-interferons, natalizumab, and fingolimod. |
2022-03-10 |
2023-08-13 |
Not clear |